NovaBay Pharma (NBY) Launches Lubricating Eye Drops
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
NovaBay Pharmaceuticals Expands Its Eyecare Product Portfolio With the Launch of Lubricating Eye Drops for the Immediate Relief of Dry Eye Symptoms
January 10, 2022 6:50 AM ESTLubricating eye drops are the first choice for dry eye symptom relief, part of the global over-the-counter artificial tears market that is expected to reach $6.4 billion by 2028
New Avenova® Lubricating Eye Drops along with Avenova Warm Eye Compress and Avenova Lid & Lash Solution comprise NovaBays "science for sore eyes" three-step daily regimen for the at-home management of dry eye symptoms
EMERYVILLE, Calif.--(BUSINESS... More
